News | Point of Care Testing | October 13, 2015

Study Shows Abbott’s High-Sensitive Troponin Test May Rule Out Myocardial Infarction Faster

Faster testing could lead to earlier discharge of majority of emergency patients with chest pain

The Lancet results, Abbott ARCHITECT STAT High Sensitive Troponin-I test, rule out myocardial infarction, Accident and Emergency, A&E

October 13, 2015 — The Lancet published results online that show Abbott’s ARCHITECT STAT High Sensitive Troponin-I (hsTnl) test may rule out myocardial infarction (MI) in two-thirds of very-low risk patients, allowing prompt discharge from A&E (Accident and Emergency). The study identified a precise new threshold of troponin of <5 ng/L which, together with other clinical factors, allows doctors to rule out heart attacks in the majority of patients, reducing prolonged waiting for monitoring with additional tests, unnecessary procedures and hospital admissions.

The study was funded by a special project grant from the British Heart Foundation and conducted by researchers at the University of Edinburgh.

Abbott’s high-sensitive test precisely measures very low levels of cardiac troponin, a protein which at increased levels can indicate injury to the heart. The use of the test helped researchers establish the optimal threshold, which resulted in an overall negative predictive value (the probability that a negative test result is a true negative) of 99.6 percent. The percentage was similar for men and women, across age groups and in patients with prior cardiovascular disease.

“The results show the high sensitive test can help doctors determine with an extremely high level of confidence that a patient may be at low risk of myocardial infarction and therefore can be safely discharged from A&E,” said Atul Anand, M.D., one of the study authors from the University of Edinburgh and Edinburgh Royal Infirmary. “This newly identified threshold has the potential to change how we diagnose patients presenting with chest pain. By establishing a troponin threshold that allows the greatest proportion of patients to be safely discharged, we have the potential to improve patient care and prevent unnecessary hospital admissions and procedures.”

In England and Wales, chest pain accounts for approximately 700,000 visits to A&E each year and patients with suspected acute coronary syndrome (ACS) are commonly admitted to hospital in order to rule out MI. Currently doctors who administer high sensitive troponin blood tests at admission, do so again within 12 hours to evaluate whether or not patients are having heart attacks. This study suggests that by using the newly identified troponin testing level, doctors have the potential to double the number of patients who are discharged directly from A&E following a single, baseline troponin test. In addition, this may provide an opportunity to lower costs incurred by healthcare systems overall.

For more information: www.abbottdiagnostics.com

Related Content

Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.

Feature | Point of Care Testing| May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on fi
Assessing Heart Disease Risk Within Arm's Reach

This figure demonstrates the histological grading scale that was used in accordance with the American Heart Association (AHA) to assign grades of atherosclerosis. The purpose of this figure is to give criteria and explain why sections were assigned specific grades. Sections are stained in hematoxylin and eosin. Stars indicate the vessel lumen. Horizontal panels represent each grade observed in the study, I-VII (excluding VI). The vertical columns depict the same sections at different magnifications. Image courtesy of Christopher Hoehmann.

News | Cardiac Diagnostics| May 03, 2017
May 3, 2017 — A new study published in...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
Non-O Blood Groups Associated With Higher Risk of Heart Attack
News | Cardiac Diagnostics| May 01, 2017
Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
AATS Consensus Statement Helps Manage Treatment of Coronary Anomalies
News | Cardiac Diagnostics| April 26, 2017
The issues surrounding congenital coronary anomalies and their effect on sudden death are complex. Researchers are...
Body Weight Fluctuations Linked to More Deaths in People with Coronary Artery Disease
News | Cardiac Diagnostics| April 25, 2017
Repeated cycles of weight loss and gain may be linked to higher risk for stroke, heart attack and death in people with...
Grey Hair Linked With Increased Heart Disease Risk in Men
News | Cardiac Diagnostics| April 14, 2017
Grey hair has been linked with an increased risk of heart disease in men, in research presented recently at EuroPrevent...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
Overlay Init